Business · 17/08/1999Updated: 10/17/2026 · 1 min read
FDA Releases Revised Guidance on Reducing Risk of Creutzfeldt-Jakob Disease Transmission via Blood Products
Summary
The FDA has released a revised guidance document outlining precautionary measures to minimize the risk of Creutzfeldt-Jakob Disease (CJD) and New Variant CJD (nvCJD) transmission through blood and blood products, replacing a 1996 guidance document.